These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A synthetic lipid A mimetic modulates human TLR4 activity. Piazza M; Calabrese V; Damore G; Cighetti R; Gioannini T; Weiss J; Peri F ChemMedChem; 2012 Feb; 7(2):213-7. PubMed ID: 22140087 [No Abstract] [Full Text] [Related]
3. Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents. Baldridge JR; McGowan P; Evans JT; Cluff C; Mossman S; Johnson D; Persing D Expert Opin Biol Ther; 2004 Jul; 4(7):1129-38. PubMed ID: 15268679 [TBL] [Abstract][Full Text] [Related]
4. Taking toll: lipid A mimetics as adjuvants and immunomodulators. Persing DH; Coler RN; Lacy MJ; Johnson DA; Baldridge JR; Hershberg RM; Reed SG Trends Microbiol; 2002; 10(10 Suppl):S32-7. PubMed ID: 12377566 [TBL] [Abstract][Full Text] [Related]
5. Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant. Casella CR; Mitchell TC Cell Mol Life Sci; 2008 Oct; 65(20):3231-40. PubMed ID: 18668203 [TBL] [Abstract][Full Text] [Related]
6. Improving the immunostimulatory potency of diethanolamine-containing lipid A mimics. Lewicky JD; Ulanova M; Jiang ZH Bioorg Med Chem; 2013 Apr; 21(8):2199-2209. PubMed ID: 23490149 [TBL] [Abstract][Full Text] [Related]
7. Synthesis of a dimeric monosaccharide lipid A mimic and its synergistic effect on the immunostimulatory activity of lipopolysaccharide. Lewicky JD; Ulanova M; Jiang ZH Carbohydr Res; 2011 Sep; 346(13):1705-13. PubMed ID: 21689810 [TBL] [Abstract][Full Text] [Related]
9. Tailored Modulation of Cellular Pro-inflammatory Responses With Disaccharide Lipid A Mimetics. Heine H; Adanitsch F; Peternelj TT; Haegman M; Kasper C; Ittig S; Beyaert R; Jerala R; Zamyatina A Front Immunol; 2021; 12():631797. PubMed ID: 33815382 [TBL] [Abstract][Full Text] [Related]
10. A novel class of endotoxin receptor agonists with simplified structure, toll-like receptor 4-dependent immunostimulatory action, and adjuvant activity. Hawkins LD; Ishizaka ST; McGuinness P; Zhang H; Gavin W; DeCosta B; Meng Z; Yang H; Mullarkey M; Young DW; Yang H; Rossignol DP; Nault A; Rose J; Przetak M; Chow JC; Gusovsky F J Pharmacol Exp Ther; 2002 Feb; 300(2):655-61. PubMed ID: 11805229 [TBL] [Abstract][Full Text] [Related]
11. Chemical Synthesis and Immunomodulatory Functions of Bacterial Lipid As. Shimoyama A; Fukase K Methods Mol Biol; 2023; 2613():33-53. PubMed ID: 36587069 [TBL] [Abstract][Full Text] [Related]
12. Design, Synthesis, and Bioactivity Evaluation of a TF-Based Cancer Vaccine Candidate Using Lipid A Mimetics As a Built-In Adjuvant. Gao L; Li G; Qiu C; Ye Y; Li X; Liao P; Ming W; Liu Z; Luo X; Liao G J Med Chem; 2024 Jun; 67(12):9976-9990. PubMed ID: 38886162 [TBL] [Abstract][Full Text] [Related]
13. Lipid A-Mediated Bacterial-Host Chemical Ecology: Synthetic Research of Bacterial Lipid As and Their Development as Adjuvants. Shimoyama A; Fukase K Molecules; 2021 Oct; 26(20):. PubMed ID: 34684874 [TBL] [Abstract][Full Text] [Related]
19. Immunology. The shape of things to come. Fitzgerald KA; Golenbock DT Science; 2007 Jun; 316(5831):1574-6. PubMed ID: 17569850 [No Abstract] [Full Text] [Related]
20. Synthetic TLR4-active glycolipids as vaccine adjuvants and stand-alone immunotherapeutics. Johnson DA Curr Top Med Chem; 2008; 8(2):64-79. PubMed ID: 18289078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]